Skip to main content

Table 1 Preoperative Characteristics of study participants stratified by BMI

From: The effects of body mass index on outcomes for patients undergoing surgical aortic valve replacement

Independent Variables

BMI < 20

(N = 108)

BMI 20–24.9

(N = 972)

BMI 25–29.9

(N = 1721)

BMI 30–34.9

(N = 1199)

BMI ≥ 35

(N = 780)

P value

Age (years)

60.1 ± 20.3

64.6 ± 16.7

66.2 ± 14.0

66.3 ± 12.2

64.3 ± 11.4

< 0.001

Male (%)

53(49.1)

647(66.6)

1304(75.8)

884(73.7)

476(61.0)

< 0.001

Chronic Lung Disease (%)

38(35.2)

309(31.8)

510(29.6)

379(31.6)

283(36.3)

0.021

Chronic Renal Insufficiency (%)

10(9.3)

94(9.7)

176(10.2)

135(11.3)

91(11.7)

0.586

Hypertension (%)

60(55.6)

576(59.3)

1193(69.3)

912(76.1)

645(82.7)

< 0.001

Hyperlipidemia (%)

60(55.6)

646(66.5)

1272(73.9)

944(78.7)

612(78.5)

< 0.001

Diabetes(%)

10(9.3)

134(13.8)

320(18.6)

372(31.0)

315(40.4)

< 0.001

Current smoker(%)

20(18.5)

147(15.1)

528(30.7)

184(15.3)

104(13.3)

0.012

Prior MI (%)

1(0.9)

24(2.5)

80(4.6)

64(5.3)

41(5.3)

0.003

Prior PCI (%)

7(6.5)

47(4.8)

130(7.6)

121(10.1)

70(9.0)

< 0.001

Prior CABG (%)

4(3.7)

34(3.5)

71(4.1)

66(5.5)

23(2.9)

0.050

PVD (%)

2(1.9)

49(5.0)

68(4.0)

53(4.4)

19(2.4)

0.048

CVD (%)

7(6.5)

106(10.9)

180(10.5)

99(8.3)

65(8.3)

0.074

Dialysis (%)

4(3.7)

19(2.0)

14(0.8)

12(1.0)

9(1.2)

0.012

Malignancy (%)

2(1.9)

34(3.5)

61(3.5)

52(4.3)

28(3.6)

0.617

Liver Disease (%)

1(0.9)

10(1.0)

20(1.2)

6(0.5)

6(0.8)

0.433

GI disease (%)

20(18.5)

147(15.1)

281(16.3)

184(15.3)

104(13.3)

0.335

Ejection Fraction

     

0.094

  < 20%

2(1.9)

13(1.3)

19(1.1)

9(0.8)

8(1.0)

 

 20–34%

10(9.3)

88(9.1)

134(7.8)

91(7.6)

54(6.9)

 

 35–50%

28(25.9)

196(20.2)

354(20.6)

213(17.8)

127(16.3)

 

  > 50%

63(58.3)

634(65.2)

1140(66.2)

847(70.6)

562(72.1)

 

 Unavailable

5(4.6)

41(4.2)

74(4.3)

39(3.3)

29(3.7)

 
  1. Abbreviations: BMI body mass index, CABG coronary artery bypass graft, CVD cerebrovascular disease, GI gastrointestinal, MI myocardial infarction, N number, PCI percutaneous coronary intervention, PVD peripheral vascular disease, SD standard deviation